Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples

International Journal of Gynecological Cancer

Volumn 19, Issue 2, 2009, Pages 266-272

  Lee, Jae Kwan ^a   Kim, Mi Kyung ^b   Song, Seung Hun ^a   Hong, Jin Hwa ^a   Min, Kyung Jin ^a   Kim, Jae Hoon ^c   Song, Eun Seop ^d   Lee, Jungpil ^e   Lee, Jong Min ^f   Hur, Soo Young ^g  

^a Korea University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Ajou University School of Medicine   (South Korea)

^f Kyung Hee University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

Author keywords

Cycle sequencing; Hpv dna chip; HPV DNA test; Hybrid Capture II; Linear Array

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ASSAY; BIOPSY; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED STUDY; CYCLE SEQUENCING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID CAPTURE II ASSAY; INFECTION RISK; INTERMETHOD COMPARISON; KAPPA STATISTICS; LINEAR ARRAY GENOTYPING ASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; ALPHAPAPILLOMAVIRUS; COMPARATIVE STUDY; GYNECOLOGICAL EXAMINATION; ISOLATION AND PURIFICATION; MICROARRAY ANALYSIS; PATHOLOGY; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ALPHAPAPILLOMAVIRUS; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS;

EID: 65649113260     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819bcd0a     Document Type: Article

References (27)

1. Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology. 2002;34:213-224.
2. Hoffmann M, Kahn T, Mahnke CG, et al. Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol. 1998;118:138-144.
3. Moore CE, Wiatrak BJ, McClatchey KD, et al. High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg. 1999;120:698-705.
4. Venuti A, Manni V, Morello R, et al. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol. 2000;60:396-402.
5. Howley PM. Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Virology 3rd, vol. 2. Philadelphia: Lippincott-Raven Inc, 1996:2045-2109.
6. Munoz N, Bosch FX, Sanjose SD, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiological classification of human papillomavirus types associated with cervix cancer. N Engl J Med. 2003;348:518-527.
7. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) STUDY GROUP. J Natl Cancer Inst. 1995;87:796-802.
8. Chichareon S, Herrero R, Munoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst. 1998;90:50-57.
9. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Eng J Med. 1992;327:1272-1278.
10. Lehtinen M, Luukkaala T, Wallin KL, et al. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and association population attributable fraction. J Clin Virol. 2001;22:117-124.
11. Shiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
12. Melchers WJ, Herbrink P, Walboomers JM, et al. Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test. J Clin Microbiol. 1989;27: 106-110.
13. Melchers WJ, Herbrink P, Quint WG, et al. Prevalence of genital HPV infections in a regularly screened population in The Netherlands in relation to cervical cytology. J Med Virol. 1988;25:11-16.
14. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003;97:1672-1680.
15. Cho NH, An HJ, Jeong JK, et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol. 2003;188:56-62.
16. Coutlee F, Gravitt P, Kornegay J, et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol. 2002;40:902-907.
17. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Micro Biol. 1997;35:1304-1310.
18. Lee GY, Kim SM, Rim SY, et al. Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int J Gynecol Cancer. 2005;15:81-87.
19. Stevens MP, Garland SM, Rudland E, et al. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smears results. J Clin Microbiol. 2007;45:2130-2137.
20. Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol. 1995;33:545-550.
21. Coutlee F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Micro Biol. 2006;44:1998-2006.
22. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol. 2000;38:651-655.
23. Giuliani L, Colleti A, Syrjanen K, et al. Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. Anticancer Res. 2006;26:3939-3941.
24. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38: 357-361.
25. Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201:1-6.
26. Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol. 1999;37:1030-1034.
27. Smits HL, Bollen LJ, Tjong AHSP, et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol. 1995;33:2631-2636.